Rezvilutamide Tablets is a prescription medication for the treatment of certain types of prostate cancer and must be used strictly under medical supervision. Key instructions cover indications, dosage, adverse reaction monitoring and contraindications. The specific regimen shall be formulated based on the patient’s condition and physician’s evaluation; do not adjust the dose or stop taking the drug without medical advice.
Precautions
Indications
Mainly used for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Eligibility for treatment must be confirmed by genetic testing or clinical diagnosis.
Dosage and Administration
Oral administration, once daily; the specific dose is determined by the doctor according to the patient’s condition.
It is recommended to take the medicine at a fixed time every day. Consult a doctor about whether to make up for a missed dose.
Contraindications
Contraindicated in patients with hypersensitivity to any ingredient of the drug.
Not recommended for patients with severe hepatic impairment, pregnant or lactating women.
Adverse Reactions
Common reactions include fatigue, hot flashes, decreased appetite, diarrhea, etc. Most symptoms are mild and controllable.
Immediately stop the medication and seek medical help if severe allergic reactions (e.g., rash, dyspnea) or hepatic dysfunction (e.g., jaundice, dark urine) occur.
Drug Interactions
Avoid concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole) or inducers (e.g., rifampicin), which may affect efficacy or increase toxicity.
Inform the doctor of all other medications being used, including health supplements and traditional Chinese medicines.
Special Populations and Monitoring
Regular monitoring of hepatic function, prostate-specific antigen (PSA) levels and disease progression is required during treatment.
Caution should be exercised in elderly patients or those with mild renal or hepatic impairment, and dose adjustment by a doctor is needed.
Male patients should use contraception during treatment and after drug withdrawal to prevent their partners from pregnancy.
Medical Guidance
Strictly follow medical advice: Do not increase or decrease the dose or change the course of treatment without authorization. Return for timely follow-up if the condition changes during treatment.
Storage: Keep in a dark and sealed place below 30°C, and keep out of reach of children.
Contact the attending physician or pharmacist immediately if you have questions about the medication or experience discomfort to avoid delayed management.
